Clinical Professor of Law, Dale E. Fowler School of Law, Chapman University
Managing Director, Berkeley Research Group
Dan Troy is Managing Director and an expert witness on FDA matters at Berkeley Research Group. Previously he served as Chief Counsel of the US Food and Drug Administration and General Counsel of GlaxoSmithKline PLC.
Bounty Hunters and the Public Interest - A Study of California Proposition 65
Anthony (Tom) Caso
INTRODUCTION Adopted by California voters in 1986, Proposition 65 was a revolutionary measure in a...
Engage Volume 13, Issue 1, March 2012
*Online-Only Issue* SPECIAL CONTRIBUTION The Philosopher in Action: A Tribute to the Honorable Edwin Meese...
FDA Labeling and State Liability
Daniel E. Troy
Were state and federal courts to defer sufficiently to FDA determinations of drug safety, the...